Skip to content
OpenCapital
AI Tools
Earnings
Screener
Charts
Watchlist
Pricing
Connect your AI
Get started
Toggle navigation menu
TriSalus Life Sciences, Inc.
TLSI
Return on equity
Return on equity at other companies
Boston Scientific
BSX
14.8%
+5.2pp
AngioDynamics
ANGO
-17.5%
-2.2pp
Delcath Systems
DCTH
1.9%
+1.0pp
Tactile Systems Technology
TCMD
9.6%
+1.5pp
LQD
Liquidia Corporation
LQDA
-181%
+57.4pp
United Therapeutics
UTHR
20.3%
+0.3pp
Other financials
Income statement
See full
Revenue
$8.9M
-2.9%
Gross profit
$7.7M
0.0%
Operating income
-$8.4M
-14.8%
Net income
$1.5M
+115%
EPS (diluted)
$0.03
+108%
Balance sheet
See full
Cash & equivalents
$56.6M
+324%
Total debt
$33.1M
+4.4%
Total equity
$12.8M
+137%
Total assets
$71.0M
+148%
Cash flow
See full
Operating cash flow
-$6.5M
-44.0%
CapEx
$141.0K
-81.3%
Free cash flow
-$6.6M
-26.0%
Valuation
See full
Market cap
$279.45M
+49.6%
Enterprise value
$255.97M
+33.6%
P/S
6.2×
+1.0×
Profitability
See full
Gross margin
85.1%
-0.5pp
Operating margin
-62.4%
-16.8pp
Net margin
-60.9%
-13.4pp
FCF margin
-45.2%
-16.8pp
Returns & leverage
See full
Debt / equity
2.6×
—
Current ratio
5.8×
+3.6×
